Skin Diseases Flashcards

1
Q

Physiology of the skin

A

•Functions of skin
•Epidermis: structure and cell types, melanin synthesis
•Dermis: structure and cell types, skin appendages
•Hypodermis
•Skin immune system
•Skin microbiome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What’s is the function of the skin?

A

Protective barrier-physical and chemical
Involved in mechanical support
Prevent loss of moisture
Reduces harmful effects of UV radiation
Sensory organ m-touch, temperature, pressure
Helps regulate body temperature
Immune organ to detect infections
Involved in production of VitD
Excretion of waste products

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Gross anatomy of the skin was

A

1-Epidermis
2-Dermis
3-Hypodermis

•Epidermis consists of 5 distinct layers
Stratum básale layer next to dermis
Stratum spinosum
Stratum granulosum
Stratum lucidum
Stratum Corneum contains layers of keratinocytes which get replaced every two days this is outer layer of skin

Major epidermis cell types:

Keratinocytes:
Main cell type
Numerous layers
Stem cells

Merkel cells present in stratum básale
Pressure attached to nerves sensory neurons different locations in the skin.

Melanocytes in stratum spinosum produce Melanin, protects from uv near to Basal region

Langerhans cells are Immune-dendritic cells in all layers of epidermis sample population of bacteria that live on cell surface of skin and detect if they are good or bad

T cells CD8 positive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Keratinocytes: structure of epidermis?

A

In the keratinocytes layer what you can see is that down in these stratum básale we have stem cells and these stem stem cells will sled renew and they rapidly proliferate and they can differentiate into any of the other cell types in this area

In stratum spinosum keratinocytes are more cuboidal cells and you can see that these keratinocytes have nuclei but as they work their way up over three to four days for instance they become more flat and once they get into the granular layer you can see they’re losing their nuclei and then once they get into the stratum lucidum there’s no nuclei left here they’re very much flattened and those dead keratinocytes on the surface will eventually flake

now the epidermal layer is not that deep it’s quite a thin layer 10-15µm and these cells in the stratum corneum are enriched with lipid and also with keratin

Keratinocytes can secrete interleukin 1 beta and this is very important in maintaining homeostasis but also an inflammation when these cells can become damaged

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

How is melanin synthesised?

A

Melanocytes produce melanin in the skin and melanin is produced from tyrosine.
Tyrosine is metabolised to Dopa then to Dopaquinone vía tyrosinase but in the presence of cysteine Dopaquinone becomes metabolised to 5,6 & 2,6 Cysteinyl-dopa then ti Benzothiazine derivatives into Pheomelanins (red pigment) ginger people/freckles.

However, Dopaquinone can also be metabolised into Leucodopachrome and into Dopachrome via Dopachrome tautomerase and into 5,6 hydroxyindole carboxylate acid and 5,6 hydroxyindole into Quinones via Tyrosine related protein-1b into Eumelanins are black/brown melanin present in darker skin.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Dermis

A

Middle skin layer 1-6mm fibrous and elastic tissue. Made of connective tissues.

Supportive and cushioning tissue composed mainly of collagen 70% and elastic and fibrillin.

The second layer in the skin is called the dermis and the dermis has two distinct layers the papillary layer of the dermis which is next to the epidermis and then the reticular layer of the dermis

The papillary layer is about 20% of the dermis is a very vascular rich region so it contains lots of capillaries and what those capillaries do is they release oxygen nutrients near the epidermis so that those bottom layers of the epidermis have sufficient oxygen nutrients and that’s why they retain their nuclei but as you go further away from the oxygen and nutrients and the capillaries of the dermis the cells become flattened in the skin in this region you get a lot of connective tissue particularly collagen and this region is called the papillary layer because of these papillae stick out and increase the surface area allowing for more exchange of oxygen and nutrients into the epidermis

The reticular region is this lower region here and this takes up the majority really of the dermis this consists of dense irregular connective tissue and these areas also have elastin and also fibrillin as well so elastin makes it more elastic and collagen makes it more strong it’s connective tissue and in this region there are several types of immune cells and number of other structures like:

Immune cells-several types
Number of structures found/
Nerve ending
Blood vessels m lymph vessels
Piloerector muscles
Sweat glands
Sebaceous glands

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Skin appendages

A

We have lots of skin appendages and different types of Corpuscles

Meissner’s corpuscles are primarily receptors for discriminative touch and are located in the dermal layer of the skin, specifically in the dermal papillae. They are sensitive to light touch and are responsible for detecting sensations such as texture and gentle pressure. I’m sorry, but that statement is not accurate. Meissner’s corpuscles are primarily receptors for discriminative touch and are located in the dermal layer of the skin, specifically in the dermal papillae. They are sensitive to light touch, not light itself, and are responsible for detecting sensations such as texture and gentle pressure. They are not located in the epidermal layer but in dermal layer of skin.

Meissner corpuscles consist of a cutaneous nerve ending responsible for transmitting the sensations of fine, discriminative touch and vibration. [1] Meissner corpuscles are most sensitive to low-frequency vibrations between 10 to 50 Hertz and can respond to skin indentations of less than 10 micrometers.

Pacinian corpuscles can detect vibrations in the skin, hair shaft root hair plexus can detect fine touch all sensory receptors.

Sebaceous oil glands and these are important because they produce oil to keep the skin and hair moist. Oil flows to surface and protects outer keratin layer of the skin. Sebaceous glands can cause problems if they get clogged can cause acne or spots.
Eccrine and apocrine sweat glands. Apocrine present in armpits and pubic regions produce protein rich sweat that supports growth of surface bacteria. Eccrine sweat glands produce watery sweat and waste products excreted products like urea and CO2. When sweat is released into skin it evaporates and this is important for regulating body temperature.

Dermis is rich in Capillaries near surface and down near básale we have venules and arterioles larger blood vessels.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Diversity of the skin at different locations

A

Face we have sebaceous glands
High density of sebaceous glands hair and eccrine glands
Environmentally exposed

Palm (dry)
Thick layer of skin
Thick stratum corneum
Hairless
High density of eccrine glands

Axilla (armpits)
Moist due to apocrine glands present
High density of hair
Occluded, humid environment.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Subcutaneous tissue (hypodermis)

A

Subcutaneous fat layer acts as a:
Mechanical layer protector
Thermal insulator
Energy store

Heat regulations uses subcutaneous fat pad (hypodermis) and skin blood supply

Thickness depends on whole body adiposity but need a minimal amount for skeletal bs organ protection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Skin immune system

A

There are many defence mechanism and different types of immune cells

In epidermis there are langerhans cells which are dendritic cells.

Other cells are CD8 positive T-cells

Keratinocytes they form a physical barrier they are involved in innate immune system and they produced cytokines like IL-1&6 important in inflammation and maintain homeostasis

Dermal layer of skin:
We have dermal dendritic cells, plasma dendritic cells, different types of CD4 cells like TH-1,2,17 cells
NKT cells, mast cells, macrophages, fibroblast and gamma delta T cells all of these produce cytokines.

If damage occurs eg wound, insect bite, toxins or allergy we get an inflammatory response from the skin immune system and this leads to inflammation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Inflammation in the skin

A

Signal mediated response to cellular insult by:

Infectious agents eg bacteria, fungi, viruses, parasites

Toxins eg chemical, radiation, UV, biological.

Physical stress eg mechanical, burns, trauma.

Protective response- ultimate goal to remove initial cause of injury and consequences of injury- the necrotic cells and tissues.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Skin microbe

A

1cm2 human skin contains up to 1b microorganisms—bacteria, fungi, viruses, mites. These microorganisms can also exist in hair shaft, sweat glands and sebaceous glands. Eg bacteria clog sebaceous glands and cause acne

Skin microbiome Beneficial:
Protect against disease

But can be Detrimental:
Exacerbate skin lesions
Promote disease
Delay wound healing
Interact with host immune system—BI-directional

Affected by lifestyle

Actinobacteria live on upper parts of body face neck

Proteibacteria live on shoulder and limbs

Firmicutes live on foot

Lots of other different classes of microorganisms live on human body Ik different regions

Skin resident microbial communities: Important for humans as they inhibit pathogens from growing in the area they take up space so pathogens don’t have space to grow also take nutrients form skin so pathogens have no nutrient to thrive.
They produce anti-microbial peptides AMPs and bactericidal compounds that can kill pathogenic compounds and can inhibit S.aureus biofilm formation.

Educate and prime adaptive immunity:

Turn local cytokine production
Epigenetically prime APCs to educate adaptive immunity
Influence regulatory T cell in epidermis.

Enhance host innate immunity:

Increase AMP production, decrease inflammation after injury and strengthen epidermal barrier.

What happens if things go wrong?

So if some change occurs to that microbial community for instance if you get an infection or for instance if you take long term antibiotics it can change the microbial community living on the skin or if you get overgrowth of these that then can lead to an inflammatory response on the skin and causes skin to produce pro-inflammatory cytokines and then you may get inflammation and the inflammation can damage the barrier to the skin that can allow both the immune system to infiltrate into the area you also get a disrupted physical barrier and that allows microbes to actually enter areas that they would normally not enter and so they penetrate sterile tissues and that can cause major problems for us

on the other hand we can have changes to our skin which can affect the microbes as well so for instance A chronic conditions such as diabetes can cause wounds to occur or injury we get an injury to that that changes the microbial community that’s on the skin because they can get taken over by potential pathogens and again these pathogens then can enter areas that they shouldn’t and cause an inflammatory response and that inflammation then can break down the barrier and can impair wound healing and cause more and more problems for us as well so this is a very important area about how the immune system in the skin communicate with the microbes that live on the surface and our microbiome is very important for that

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Wound healing lecture
What is a wound?

A

A wound is a break in the epithelial integrity of the skin may affect deeper layers even to bone.

•Types of wounds
•Stages of acute wound healing
•Chronic wound and impaired •Diabetic ulcers
•Aging

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the types of wounds?

A

•Superficial:
Damage to epithelium
Heals rapidly through regeneration of epithelial cells

•Partial thickness:
Involves dermal layer
Vascular damage

•Full thickness:
Involves subcutaneous fat and deeper
Longest to heal-new connective tissues required
Contraction during healing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the 4 main stages of wound healing?

A

First stage:
Injury to skin causes bleeding to occur this is called hemostasis, this forms a blood clot to stop bleeding.

Second stage:
Inflammation; inflammatory phase to stop any infection from occurring lots of immune cells fight infection and body wants to provide a new frame work for new blood vessel growth.

Third stage:
Proliferation or proliferative stage body makes new connective tissues to replace damaged tissue and to pull the wound closed. A new epithelial or epidermal layer is formed

Fourth stage:
Remodelling to bring skin back to normal decrease amount of immune cells in the area contract area back to normal and a vascular scar on surface is apparent at that stage.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How long does it take for wound healing to occur?

A

First stage bleeding and homeostasis take less than 1 day

Inflammatory stage takes anything between 1-10days but after 1-day neutrophils increase to initiate inflammation to it is peak amount. During this time granulocytes, phagocytosis, macrophages, neutrophils and cytokines initiating a response after 2-3days after a wound. This helps reduce or prevent infection or bacteria but they also ingest dead tissues so body can replace or form new tissues.

After 3 days we get proliferation phase this is when we began to deposit matrix down, body starts to make collagens, fibronectin, proteiglycans and they are all involved in connective tissue; where fibroblasts are proliferating, angiogenesis new blood vessel formation, re-epithelialization forming delicate cover over wound laying down extracellular matrix.

1 month after the wound has occurred last phase occurs which is Matrix remodelling, strengthening occurs, increase in tensile strength, decrease in cellularity and vascularity of area. Remodelling of connective tissue and cellular matrix. Can take up to a year for skin to get back to normal after a wound depending on depth of wound.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What cells & mediators are involved in acute wound healing?

A

After tissue injury bleeding occurs then inflammation phase; macrophages and neutrophils will produce cytokines, pro-inflammatory cytokines, growth factors (GF) eg MMP, ROS, hydrogen peroxide, IL, TNF, VEGF, TGFB, FGF, PDGF. These growth factors help connective tissue and blood vessels to start growing.

•Granulation and neoangiogenesis
Fibroblasts, macrophages, endothelial cells, MMPs, prolyl hydroxylase, IL, TNF, TGFbeta, VEGF, PDGF, KGF.

•Re-epithelialization (covering of wound)
Keratinocytes, MMPs, EGF, KGF to strengthen and rebuild the epidermis.

•Tissue remodelling
Fibroblasts crosslinks collagen fibre cross-linking to strengthen the area, MMPs, TGFbeta however this stage is not reached sometimes due to chronic inflammation and that can lead or sustained inflammation then causes a chronic wound.

AI:

After tissue injury, a series of biological processes occur to facilitate wound healing. The passage mentions several key factors and cell types involved in the different stages of wound healing.

  1. Hemostasis and Inflammation:
    Following tissue injury, bleeding occurs, leading to the formation of a blood clot. This process, known as hemostasis, helps to stop the bleeding. Subsequently, the inflammatory phase begins, involving the activation of immune cells such as macrophages and neutrophils. These cells produce various molecules called cytokines, including pro-inflammatory cytokines. Additionally, growth factors such as matrix metalloproteinases (MMPs), reactive oxygen species (ROS), hydrogen peroxide, interleukins (IL), tumor necrosis factor (TNF), vascular endothelial growth factor (VEGF), transforming growth factor-beta (TGFB), fibroblast growth factor (FGF), and platelet-derived growth factor (PDGF) are secreted. These factors play a crucial role in promoting the growth of connective tissue and blood vessels, aiding in the next stage of wound healing.
  2. Granulation and Neoangiogenesis:
    During this stage, various cell types, including fibroblasts, macrophages, and endothelial cells, contribute to the formation of granulation tissue. Granulation tissue is characterized by the formation of new blood vessels (neoangiogenesis) and the deposition of extracellular matrix components. The production of MMPs, prolyl hydroxylase, IL, TNF, TGFbeta, VEGF, PDGF, and keratinocyte growth factor (KGF) is involved in this process.
  3. Re-epithelialization:
    Re-epithelialization refers to the covering of the wound with a new layer of epithelial cells. Keratinocytes, a type of skin cell, play a crucial role in this stage. MMPs, epidermal growth factor (EGF), and KGF are involved in the proliferation and migration of keratinocytes, facilitating the strengthening and rebuilding of the epidermis.
  4. Tissue Remodeling:
    In the final stage of wound healing, tissue remodeling occurs. Fibroblasts are responsible for crosslinking collagen fibers, which helps to strengthen the wound area. MMPs and TGFbeta are involved in this process. However, it is important to note that chronic inflammation can hinder or delay the progression to this stage, leading to the development of chronic wounds.

References:
1. Guo S, Dipietro LA. Factors Affecting Wound Healing. J Dent Res. 2010;89(3):219-229. doi:10.1177/0022034509359125
2. Eming SA, Martin P, Tomic-Canic M. Wound repair and regeneration: mechanisms, signaling, and translation. Sci Transl Med. 2014;6(265):265sr6. doi:10.1126/scitranslmed.3009337

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What is haemostasis?

A

Micro vascular injury- blood seeps into wound

Injured vessel contract

Coagulation cascade activated by tissue factor aims for Clot formation and platelet aggregation.

Platelet aggregate into that area as well, platelets trapped in clot release PDGF, IGF,EGF,TGF-beta which attract and activate fibroblasts, macrophages and endothelial cells.

  1. PDGF - Platelet-Derived Growth Factor
  2. IGF - Insulin-Like Growth Factor
  3. EGF - Epidermal Growth Factor
  4. TGF-beta - Transforming Growth Factor-beta

Also serotonin is released, which increases vascular permeability.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Inflammatory phase?

A

•Early inflammatory phase:

Activation of complement

Infiltration of neutrophils within 24-38h Diapedesis into wound and phagocytosis of bacteria and foreign particles, with ROS and degrading enzymes-prevent infection

Dying cells cleared by macrophages or extrusion to wound surface.

•Late inflammatory phase:

Blood monocytes arrive and become macrophages 48-72hrs

Key cell type for repair in wound healing

Cytokines and growth factors to recruit fibroblasts, keratinocytes and endothelial cells to repair damage

Collagenases to degrade tissue
Poor wound healing when inadequate monocytes/macrophages.

Lymphocytes enter wound >72hr and are involved in remodelling

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Proliferative phase

A

Proliferative phase 72h-2wks

•Fibroblast migration
Produce fibronectin, hyaluronan, collagen, priteiglycans.
Proliferate and construct new ECM

•Collagen synthesis: strength and integrity

•Angiogenesis
TGF beta and PDGF from platelets, TNF and bFGF from macrophages.
Capillary sprouts invade fibrin/fibronectin-rich wound clot and organise micro-vascular network

•Granulation tissue formation
Mainly proliferating fibroblasts, capillaries, macrophages in matrix of collagen GAGs and fibronectin and Tenascin.

•Epithelialisation
Single layer of epidermal cells migrate from wound edges to form delicate covering, basal cells increases proliferation ñ, new basement membrane

EGF stimulates epithelial mitogenesis and chemotaxis, bFGF and KGF stimulate proliferation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Remodelling phase- long time

A

Matrix matures and remodels
Fibronectin and HA broken down
Collagen bundles increase in diameter and strength (80% of strength of original)

Ongoing collagen synthesis and breakdown by TGF-beta and MMPs

Collagen becomes more organised and shrink to bring wound margins closer together.

Fibroblasts and macrophages apoptose
Capillary outgrowth halted and blood flow reduced
Acellular, avascular scar results

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Chronic wound and impaired healing

A

When normal process of healing disrupted at one of the stages, usually inflammatory or proliferative.
Disturbance in growth factors, cytokines, proteases, cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Local factors affecting wound healing eg post surgical

A

Pressure
Mechanical injury/trauma
Infection/foreign substances
Oedema
Necrosis
Topical agents
Lack of oxygen delivery ischemia
Desiccation and dehydration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Systemic factors affecting wound healing eg postsurgical

A

Old age
Obesity
Chronic disease eg diabetes, anemia connective tissue disorders
Immunosuppression
Smoking malnutrition
Vascular insufficiency
Stress
Radiation or chemotherapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

What causes chronic wound?

A

Neuropathy in diabetes mellitus, spinal injuries

Ischemia in atherosclerosis, PVD, microangiopathy DM

Peripheral oedema
DVT, Varicose veins, renal or cardiac failure

Pressure
Poor stability, spinal cord injuries, Dementia, diabetes mellitus, old age, terminal illness.

Other connective tissue disorders leading to vasculitis, systemic diseases, malignancy, smoking, drugs such as corticosteroids and hydroxyurea.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

What are the clinical features of chronic wound?

A

Presence of necrotic and unhealthy tissue
Excess exudate and slough
Lack of adequate blood supply
Absence of healthy granulation tissue
Failure of re-epithelialisation
Cyclical or persistent pain
Recurrent wound breakdown
Clinical or sub clinical infection.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Diabetic ulcers affect on wound healing

A

There can be motor/sensory or autonomic neuropathy

If there is motor neuropathy damage to neurons and neuron message signal is terminated this results in muscle atrophy. This causes a change in gait (new pressure distribution) and leads to ulcers.
Motor neuropathy can also cause bone changes which leads to deformed foot and ulcers

Sensory neuropathy you can’t detect pain if injury occurs you get painless trauma. If body is injured no pain is detected so could lead to wound and ulcers and complications of ulcer is infection and gangrene (localized death and decomposition of body tissue, resulting from obstructed circulation or bacterial infection.)

Autonomic neuropathy:

Decreased sweating so excess drying of skin occurs. Cracks in skin can cause chronic ulcers.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Eczema (dermatitis)

A

Eczema (dermatitis) both terms used interchangeably. Eczema inflammation of the epidermis and dermatitis inflammation of the dermis but both occur simultaneously.

Group of skin conditions that cause dry, irritated, inflamed skin.

Inflammatory reaction of the skin:
_Erythema, oedema, oozing, papeles, crusting, thickening and slacking.
_Itching, burning.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

What are the different types of eczema?

A

Atopic dermatitis
Contact dermatitis
Seborrhoeic dermatitis
Dyshidrotic dermatits
Nummular dermatitis
Neurodermatitis
Stasis dermatitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Atopic dermatitis

A

Chronic disorder with flare ups and remissions-May clear up for long periods

Most common form of eczema 1-2% adults, 15-20% school children
30% of skin problems in general practise
Manley’s and femalesbequally affected

Type IV hypersensitivity reaction
Often occurs with asthma or hay fever (atopic triad)
Commonly affects knees, elbows, wrists, neck, face.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Atopic eczema

A

Genetic predisposition-atopic families
Defects in the skin barrier-repair and maintain
Lack of anti-microbial peptides
Defect in the fliaggrin gene-important for maintaining the skin barrier-in most eczema patients.

Abnormalities in the normal inflammatory and allergy responses

Barrier defects makes the skin in affected patients m uh more susceptible to infection and to irritation and allow allergy inducing substances to enter the skin, causing itch abs inflammation.

Abnormalities in the normal inflammatory and allergy responses
Barrier defects makes the skin in affected patients much more susceptible to infection and to irritation and allows allergy inducing substances if enter the skin, causing itch and inflammation.

Immunology of eczema:

Allergen in the skin gets taken up by the dendritic cells are the langerhans cells in epidermis and dermis.
Dendritic cells present antigens to the T-cells, there is a change in the balance of TH1&2 cells so expansion occurs in TH2 cells and this secretes IL-4 activates B-cells to change antibody class and they start to produce IgE, this travels in the blood to mast cells it gets taken up by high affinity receptors on the surface of mast cells and this allows allergens to be taken up, this causes a release of pro-inflammatory mediators that cause the inflammation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

What are the clinical features of atopic eczema?

A

Often age specific:
Felxural eczema in children
Hand eczema in adults

Dry skin
Itching, May be severe, especially at night
Red to brownish grey patches in affected areas become lichenified
Raw, sensitive, swollen skin from scratching skin infections and sores can occur when scratching breaks the skin.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

How to prevent flare ups?

A

Moisturisers to prevent drying of the skin
Identify and avoid triggers if possible
Mild soaps and short showers/baths

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Treatment of the atopic dermatitis?

A

Emollients to keep skin moisturised
Topical corticosteroids work locally to inhibit the inflammation
Antibiotics if eczema infected
Phototherapy

Next step in treatment:

Systemic corticosteroids if patient doesn’t respond or experiences s/e next step is to use
Topical calcineurin inhibitors TCIs eg pimecrolimus and tacrolimus. These inhibit T-cell response so prevents T helper cells from releasing IL-4.

Next step in treatment is immunosuppressants- ciclosporine, Azathioprine
Dupilimumab-mAb inhibiting IL4/IL13 signalling, inviting switching of classes from b-cells to T-cells.

Alitretinoin-for chronic hand eczema refractory to steroids (retinoids)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

What’s contact dermatitis?

A

Contact dermatitis cause by many substances in the home or work place responsible
Usually exposed parts of the body

2types of contact dermatitis:

•Irritant contact sue to toxic insult or accumulative exposure to some type of toxin or just long term use of water

•Allergic contact
Can distinguish between irritant and allergic contact via a patch test

More common in adults than children
Common in wet work- healthcare, hairdressers, catering, labs, cleaners, industrial factory workers.

Atopic eczema patients have increased susceptibility to both types

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

What is irritant contact dermatitis?

A

75% of cases
Exposure to acute toxic insult or cumulative damage from irritants

Detergents and solvents which strip skin of natural oils
Amount of exposure important

Excessive hand washing, dribble rashes or nappy rashes

Occurs under rings

Diagnosis by knowing which substances irritate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

What is allergic contact dermatitis?

A

•Majority of occupational skin disorders

•Type IV hypersensitivity reaction

•Over time of exposure, immune response builds up

•Nickel, rubber, perfumes, preservatives in cosmetics, dyes

•Diagnosis by patch testing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

Pathogenesis of AD, ICD, ACD?

A

•Atopic dermatitis:

Allergen gets taken up by dendritic cells which then presents allergens to T-cells in the lymph node
T cells cause B-cells to have IgE class switching; triggers mast cells to produce many pro-inflammatory mediators which switches on many cells involved in this adaptive immune response, increases production of lots of different cytokines that will disturb epithelial barrier and causes more water loss.

•Irritant contact dermatitis:

Innate immune twosome occurs in ICD. The irritant will directly affect the keratinocytes and this will switch on and secrete many Pro-inflammatory cytokines such as TNF, IL-1, IL-8, GM-CSF and it will switch on dendritic cells via IL-1 secretion.
This activates the up regulation of endothelial cells this allows vasodilation to occur and this allows cellular recruitment in the skin area eg recruitment of neutrophil followed by monocytes which become macrophages, lymphocytes and mast cells. This causes a local inflammatory response. This is innate immunity

•Allergic contact dermatitis:
Consists of a combination of both adaptive and innate immune response

Allergic contact dermatitis is a type of delayed hypersensitivity reaction that occurs when the skin comes into contact with an allergen. The pathogenesis of allergic contact dermatitis involves both adaptive and innate immune responses.

  1. Sensitization Phase:
    - Allergen Penetration: The allergen, such as nickel or fragrance, penetrates the skin and is taken up by dendritic cells (DCs) present in the epidermis.
    - Presentation to T-Cells: The DCs migrate to the nearby lymph nodes, where they present the allergen to T-cells. This interaction leads to activation and differentiation of allergen-specific T-cells.
    - B-Cell Activation: Activated T-cells produce cytokines that promote B-cell class switching to IgE production. B-cells then produce allergen-specific IgE antibodies.
    - IgE Production: The IgE antibodies bind to high-affinity receptors (FcεRI) on mast cells and basophils, sensitizing them to the specific allergen.
  2. Elicitation Phase:
    - Re-Exposure to Allergen: Upon re-exposure to the allergen, it binds to the IgE antibodies on mast cells and basophils.
    - Mast Cell Activation: Cross-linking of IgE receptors on mast cells triggers the release of various pro-inflammatory mediators, including histamine, leukotrienes, and cytokines.
    - Inflammatory Response: The released mediators cause vasodilation, increased vascular permeability, and recruitment of inflammatory cells, such as neutrophils, monocytes/macrophages, lymphocytes, and additional mast cells.
    - Epithelial Barrier Dysfunction: The pro-inflammatory cytokines released by mast cells and other immune cells disrupt the epithelial barrier, leading to increased water loss and further inflammation.

The combination of mast cell activation, release of pro-inflammatory mediators, and recruitment of immune cells results in the characteristic symptoms of allergic contact dermatitis, including redness, swelling, itching, and skin lesions.

It’s important to note that the pathogenesis of allergic contact dermatitis may vary depending on the specific allergen and individual immune response.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

Treatment of contact dermatitis?

A

Avoid irritants and allergens
Use emollients
Topical corticosteroids
Oral corticosteroids
Alitretinoin (vitA form) for chronic hand contact dermatitis refractory to steroids (retinoid)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

Seborrhoeic dermatitis in adults

A

1-3% uk population
More common in males bd over age of 20

Common harmless rash wig skin flakes, itchy and sore inflamed red skim with greasy looking white or yellow scales

Ranges from mild dandruff to severe on the scalp

Sebaceous skin zones- face, scalp, chest, ears, skin folds, acúlale, groin

Sue to overgrowth of malassezia yeasts, which are part of the normal skin flora but trigger inflammatory response

Not contagious, aggravated by stress

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

Seborrhoeic dermatitis (infantile)

A

Infants aged 3-8 months
Yellow, waxy, scales ok scalp, thick and difficult to remove

Pink flaky patches on forehead, eyebrows, behind ears, nappy area.
Due to developing sebum glands.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

Seborrhoeic dermatitis-treatment

A

Infants:
Emollients or minerals for scalp
Topical steroids with antifungal for body

Adults
Shampoos with ketoconazole, Zn pyrithione, Se sulfide (anti-yeast)

Steroid scalp lotions/mousses
Topical mild corticosteroids with salicylic acid for scalp
Topical mild corticosteroids with anti-yeast creams-ointments (clotrimazole, miconazole and nystatin)

In severe cases and if above treatment fail use Oral antifungals ( severe cases)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

What are the other types of eczema?

A

•Nummular (discoid) dermatitis:

Round oval blistered dry lesions
Usually lower legs/ trunk arms
Affects males and females equally
Unknown cause
Treat with emollients, steroids, antibiotics and phototherapy.

•Neurodermatitis:
12% of the population, commonly mid to late adulthood esp 30-50yesrs

Localised area caused by repeated rubbing it scratching.
Possibly due to compressed nerve or presence of other dermatitis.
Very persistent and recurring
Treat with emollients and topical steroids.

•Stasis dermatitis:
Adults with varicose veins, DVT, or ulcers or where increased pressure in the veins of the leg.

Other risk factors- overweight, standing up
More common in women
Often associated with signs of venous hypertension
Skin become fragile, thin, shiny, inflamed, itchy abs flaky.

Treat with emollients, steroids, compression stocking, exercise, weight loss, elevation of the legs and surgery for varicose veins.

•Dishydrotic dermatitis

Common in people with atopic eczema under the age of 40
Affects hands and feet
Unknown cause but aggravated by heat and stress
Tiny itchy blisters
Treat with emollient, steroids, antibiotics, systemic immunosuppressants and phototherapy.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

Psoriasis

A

Chronic autoimmune disease, inflammatory skin disease with periods of remission and relapse.

Affects 2-3% of uk population
Equally in men and women at any age
Peaks in late teens-early 30s and 50-60

Normal skin cells produced faster than they are shed resulting in itchy, skin lesions/plaques—pink/red with white scales variety of shapes and sizes- can split-painful.

Can develop psoriatic arthritis.

45
Q

What are the different types of Psoriasis?

A

Plaque psoriasis
Scalp psoriasis
Guttate psoriasis
Pustular psoriasis
Nail psoriasis
Psoriatic arthritis
Psoriasis in sensitive areas- armpits, genitals and skinfolds.

46
Q

Plaque psoriasis

A

Is most common type of psoriasis can occur alone or in combination with other types.
Red, itchy, sores plaques with white or silvery scales-well demarcated.
Occurs anywhere on body- usually different type of on palms or soles or where skin touches skin.

47
Q

Types of psoriasis

A

•Scalp psoriasis

similar to other parts of body but thick build up of scaly skin leading to dandruff like flakes
Also visible around the hairline, forehead, neck and ears
If severe can cause thinning of hair

•Guttate psoriasis

Bring the pink or red on fair skin less red and more darkening on dark skin

Widespread across torso, back, limbs
Usually eventually clears up m common in children and younger adults
Often triggered by strep throat

•Pustular
Small white or yellow fluid filled blisters pustules on top of red or darkened skin m—turn crusty when burst
Palms of hands or soles of feet
Can become generalised
Can be painful and require dermatologist for treatment

•Nail psoriasis

Up to 50% of psoriasis and 80% of psoriatic arthritis patients
Can affect only the nails
Fingernails and or toenails
Mild to severe and often mistaken for fungal infection
Nail discolouration, putting, crumbling, cracking m, splitting, detaching

48
Q

Guttate psoriasis

A

Bring the pink or red on fair skin less red and more darkening on dark skin

Widespread across torso, back, limbs
Usually eventually clears up m common in children and younger adults
Often triggered by strep throat

49
Q

Aetiology
What causes psoriasis?

A

Genetic predisposition
Complex inheritance but 1in4 children of affected parent
Several susceptibility loci

Keratinocytes normally take 3-4 weeks from basal layer to shedding but this occurs in 3-4 days in psoriasis.

Inflammatory cells increased in all layers

Trigger often outside event—eg throat infection (streptococcal), stress or injury to skin, virus (HIV or HPV) or withdrawal of corticosteroids.

50
Q

Pathogenesis of Psoriasis?

A

Genetic predisposition of the genotype PSORS-1 or IL-23R, IL-12B in combination with environmental stress eg microorganisms, trauma, drugs or stress combined can cause stress in the keratinocytes cells, this triggers production of pro-inflammatory cytokines that will activate dermal dendritic cells. At the same time keratinocytes breakup so their DNA is released. Keratinocytes also produce anti microbial peptides including LL-37, the DNA that is released and LL-37 combine to form complexes and our immune system doesn’t recognise these complexes and classifies them as foreign these then are taken up by dendritic cells and they present them to T-cells. Dendritic cells also release IL-23 and IL-12 this switches on T cells and clinal expansion occurs resulting in formation of TH1&17 helper cells.
These T-cells produce cytokine we get TH1 cells response means we get production of interferon gamma and TNF-a and they activate the dendritic cells again and the keratinocytes which causes more inflammation as keratinocytes produce chemokine and these chemokine offer a chemokine gradient that allows T-helper cells and our macrophages to get into keratinocytes layer.
We get local expansion of T-cells and also the cytotoxic T-cells play a role here and we get more production of pro-inflammatory cytokines that help keratinocytes to grow more so all the growth factors KGF, EGF, TGF cytokine.

Hyper proliferation of the keratinocytes layer and also get activation of fibroblasts.
All of this means more production of collagen
So keratinocytes made too quickly and body doesn’t have enough time to shed them off.

51
Q

How is psoriasis treated?

A

Unique to each individual
Topical treatment
•Moisturisers and emollients to prevent water loss and drying or flaking.

•Vitamin-D derivatives (calcipotriol) tacalcitol, calcitriol) inhibit proliferation of cells and induced differentiation of keratinocytes and that slows down the excess growth.

•Dovobet (betamethasone, and vitD derivatives)

•Coal tar preps-scalp anti inflammatory and anti-scaling

•Dithranol for well defined plaques not in sensitive areas

•Topical calcineurin inhibitors which inhibit T-cell responses.

However if these don’t work we can use
•Phototherapy

*Systemic treatments:

•Immunosuppressants-methotrexate and Ciclosporin

•Vitamin A derivative (Acitretin)

•Apremilast-inhibits phsophodiesterase 4 which causes local inflammation

•Dimethyl fumarate- activates Nrf2 which is involved in modifying responses against oxidative stress and inhibits inflammation too.

•Anti-TNF (infliximab, adalimumab, etanercept, certolizumab)

•Anti-IL23 (Ustekinumab (anti-IL12&23), guselkumab, rizankizumab, tildrakizumab)

•Anti-IL17/IL17A ( secukinumab, brodalumab, ixekizumab)

52
Q

What’s Psoriatic arthritis?

A

Inflammatory joint diseas affecting north joints (eg knees, hand and feet) and tendons (eg heel and lower back)

Relapsing band remitting
Generally occurs after skin lesions
Not linked to severity of psoriasis
Joints become tender, swollen and stiff—worse in the morning and ease with exercise.
Inflammation of tendons without joints
Often associated with nail psoriasis

53
Q

Treatment of psoriatic arthritis?

A

Painkillers
NSAIDs eg ibuprofen, Diclofenac, COX-2 inhibitors

Corticosteroids
DMARDs Leflunomide
Biologicals
Anti-TNF adalimumab, etanercept, certolizumab
Aprémielast—anti-PDE4
Tofacitinib-JAK inhibitor

54
Q

Other Skin Pathologies

A

•Acne

•Skin cancer

•Infections:
Warren
Verrucas
Impetigo
Fungal infections

•Pigmentation changes
Vitiligo

55
Q

What’s Acne?

A

Acne is very common and it is Characterised by blackheads abs whiteheads and pustules.
Mostly affects face, upper part of chest, and the back where most sebaceous follicles.

Severe acne results in inflammation but acne can also manifest in non-inflammatory forms.
Lesions are caused by excess oil and dead skin cells clogging up follicles- propionibacterium acne grow, triggering inflammation and pus.

In adolescence, acne is usually caused by an increase in testosterone, which accrues during puberty.

Acne scars are the results of inflammation within the dermis brought by acne (1 in 5 suffered have scarring)

Benzoyl peroxide, antiseptics m, antibiotics, hormonal treatment and retinoids.

56
Q

What’re the different types of skin cancers?

A

Basal cell carcinoma
Squamous cell carcinoma
Malignant melanoma

57
Q

What’s basal cell carcinoma?

A

Slow growing and locally invasive tumours

4times more common than other skin cancers

Caused by UV exposure and proliferation of basal keratinocytes

Commonly on head and neck

Morbidity related to local tissue invasion and destructions

Imiquimod cream treatment enhances the immunity in the area which tries to kill off cancer cells.

58
Q

What’s squamous cell carcinoma?

A

Malignant invasive proliferation of epidermal keratinocytes.

Second most common skin cancer
More common in men abs the elderly
Caused by UV exposure
Common in white skins that burns easily
Also caused by topical carcinogens-arsenic or chronic immunosuppression

With treatment overall remission rate is 90%

59
Q

What’s malignant melanoma?

A

Malignant melanoma is an aggressive form of skin cancer due to changes in the melanocytes. Malignant proliferation of melanocytes.

Incidence and mortality are increasing with highest incidence in Australia and New Zealand.
It caused by UG exposure
Mortality rate of 25%
Limited treatment options
Recent high profiles successes of immune system modulation

60
Q

Risk factors & signs of melanoma?

A

UV exposure
Intense short exposure in childhood
Fair skin
Red and blonde hair
Blue eyes
Difficulty to tan
Freckles
Benign naevi/dysplasia naevi

Signs of melanoma:

Asymmetry
Boarder is irregular
Colour variegation
Diameter >6mm
Evolving-any changes in size, shape, colour, elevation bleeding, itching crusting.

Increasing rates in both men and women peak incidence at 40-60yrs of age
In women it affects in legs and in men it is more common in trunk

61
Q

Pathogenesis of skin cancer?

A

In the epidermis we have melanocytes at the basal layer, proliferation occurs that can turn into benign moles or benign nevus that is fine but sometimes it can grow out of control and form a dysplastic nevus and these cause asymmetrical moles
The next phase is called the radial growth phase. During this phase, the cancer cells grow horizontally along the surface of the skin in the epidermis but then we get vertical growth and start to expand in the terminal layer and eventually become metastatic because they reach the blood vessel in the area and they can leave the area and move to other areas to form metastasis in the brain bone or liver.

62
Q

Breslow Thickness

A

<1mm: 5-year survival is 95-100%
1-2mm: 5-year survival is 80-96%
2-1-4mm: 5-year survival is 60-75%
>4mm: 5-year survival is 37-50%

63
Q

Treatment of skin cancer?

A

Surgery:

Simple or wide
Sentinel node biopsy
Take biopsy of the nearest lymph node and look for cancerous cells shows if cancer has left area or not.

Chemotherapy
Cytotoxic drugs such as Dacarbazine iv infusion which patients become resistant to quickly or Temozolomide oral. Taxanes (docetaxel, paclitaxel) and platinum agents.

More recently:
Target therapy
Interferon alpha 2b
IL-2
Ipilimumab (anti-CTLA4)
Anti-BARF
Anti-PD1

64
Q

New anti-melanoma therapies?

A

Melanoma cells grow due to growth factors epidermal growth factors stimulate these cells through receptor tyrosine kinases to stimulate RAS then BRAF then MEK then ERK.
BRAF in melanoma cells about 40-50% of patients have BRAF mutations you can target this and this actually reduces the growth of melanoma cells.

Another target is targeting protein to protein interactions which is the CTLA4 which is present on T-cells and B7 on melanoma cell or Pd-1 on T-cells and PD-L1 on melanoma cell. These block if you use antibodies to these protein to protein interactions they block the immunological check points that would result in adaptive immune resistance so the melanoma cells don’t become resistant to T-cells that try to kill it off.

65
Q

What is Warts?

A

Small, rough growth, typically hands or feet.

Several different types and shapes
Common-rebound, firm, raised, knuckles
Verrucas- white, soles of feet, flat
Plan- clusters-yellowish, smooth, young
Filiforme-long, slender, neck and face
Periungual-nails, change shape, painful
Mosaic-tile-like clusters, palms and soles.

66
Q

Warts and verrucas

A

Caused by human papillomavirus-causes excess keratin production on epidermis.

Virus can spread through close skin to skin contact, contaminated objects eg towels, shoes, communal changing areas, more likely to spread if skin wet, soft and in contact with rough surface.

Clear up after 2 years.
Salicylic acid containing creams, gels and paints
Cryosurgery

Genital warts- very common, sexually transmitted

Months or eve after years to develop after HPV infection.

Liquids and creams eg lmiqumoid, topical cream that stimulates the immune system to fight papillomavirus by encouraging interferón production.
Keratolysis and cryosurgery.

67
Q

What’s impetigo?

A

Common highly contagious skin infection causing sores and blisters_often Streptococcus/Staphylococcus infections.

2 types:

•Non-bullous-most common- nose and mouth, sores quickly burst- leave yellow brown crust.

•Bullous-trunk, fluid-filled blíster that burst after few days- leave yellow crust.

Very common in young 1/35 children in uk aged 0-4
Topical antibiotics, stay away from other people
Severe cases-systemic antibiotics
(eg flucloxacillin)

68
Q

Fungal infections?

A

Several types of infections eg dermatophytes and Yeats, results in inflammation.
Fungi invade abs grow in dead keratin
Dermatophytes
Athletes foot
Ringworm growing between toes
Itchy flaky red skin
Contaminated floors
Nail infections usually toenails—start from edge to base
Ringworm-body, scalp, groin

Small areas treated with topical applications of imidazole 2%

Severe cases with systemic antifungal agents (griseofulvin, itraconazole)
Immunocompromised patients (Candida, and aspergillus) m

69
Q

Pigmentation disorders

A

Hypopigmentation:
Vitiligo
Decreased production of melanin
Albinism
Infection, blisters
Burns
Phototherapy

Hyperpigmentations:
Enhanced melanin production
Pregnancy, Addisons disease
UV exposure
Antibiotics and anti-malarials
Hydroquinone

70
Q

Vitiligo

A

Vitiligo also called leucoderma
Loss of skin colour in patches-discoloured areas usually get bigger with time.
Affects any parts of the body, hair and inside the mouth but more around the eyes, nostrils, mouth, navel, knees, and elbows.

Melanocytes die or stop functioning leading to loss of melanin

Affects people of all races and all skin types
95% develop it before age 40
Not contagious or life threatening and not linked to cancer
No cure

3 types:
Focal, segmental, generalised

Aetiology
Auto immune component
30% of patients have a family history
15-24% have autoimmune disease
Immune system attacking its own melanocytes
Trigger stress, skin damage, hormonal m changes, chemical exposures (phenol) m, liver/renal disease.

Pathogenesis:

Auto immune component
Body makes autoantibodies to tyrosine hydroxylase in non-segmental vitiligo
Increase in ROS production also in mitochondria of affected cells.

71
Q

Skin formulations and therapies

A

Important target for drug therapy and cosmetics, lotions and other agents.

Cosmeceuticals-huge market, many with no proof of efficacy. Reasons vary from beauty, anti-ageing.

Skin vital route of drug administration in dermatology

Topical applications of drugs onto skin not only for skin disorders but can be used as systemic route of administration eg NSAIDs applied to underlying inflamed joints and connective tissue.

72
Q

Skin formulation

A

Advantage: drug can be applied directly to diseases tissue

Disadvantage: skin is a highly effective barrier, so can prevent entry of medicines.

Site of action-often lower layer if epidermis or dermis so has to pass through lipid rich layers of epidermis—leads to special issues with transdermal delivery.

Special formulations required to promote skin penetration:
Eg glucocorticoids derivatised with fatty acid esters to enhance absorption
Eg waterproof occlusion dressing to cover skin after drug application to keep epidermis hydrated.

73
Q

Rationale of drug delivery to and via the skin?

A

To skin:
Manipulate the barrier function of the skin.
Infection use topical antibiotics and antibacterial
UV Protection: sunscreen and emollient preparation to restore pliability to dry stratum corneum layer

Via skin:
Skin delivery for systemic treatment
Transdermal patch for treatment of motion sickness
Transdermal patch fit systemic delivery in angina.

74
Q

Topical and transdermal delivery?

A

Topical:

Intended for external use
Localised action on one or more layers of the skin.
But some little bit of drug still reaches systemic circulation (Reach systemic circulation in sub-therapeutic drug concentration)

Skin softening emollient
Examples of topical formulation:
Solutions (erythromycin)
Collodion (salicylic acid)
Suspensions (selenium sulfide)
Emulsions (lotion)
Semisolids (ointment, pastes, gels, and creams)
Solids (powders, aerosols)
Spray (lidocaine)

Transdermal patches:

Intended for external use, skin is not the primary target
Drugs transport through percutaneous route to systemic circulation.

Nicotine patch, hormones.

75
Q

Skin formulations

A

•Cream/ointments:
Formulations tailored to specific drugs-be bile for dissolving drug important.
Water in oil emulsion for Ciclosporin as hydrophobic
Oil in water for NSAIDs as hydrophilic
Appearance and odour important.

Agents to protect skin abs promote repair:
Emollients-rehydrate the skin
Barrier creams-prevent damage from irritants

•Novel technologies-nano carriers

•Ointment: semi-solid
Hydrophobic ointment bases eg paraffin, fats and fixed oil bases eg caster oil, silicones, emulsifying bases eg aqueous cream m, water soluble bases eg polyethylene glycols.

•Creams-semi-solid of O/W or W/O

•Pastes-semi-solid eg dental paste

•Gels-liquids gelled eg Ibugel

•Others eg poultices, medicated plasters, powders, aerosols.

76
Q

Five target regions in dermatology

A

1-Surface treatment
•protective layer, insect repellent, anti-microbial, anti-fungal, sunscreen.

2-Stratum Corneum
•emollient, keratosis

3-Skin appendage
•Acne, antibiotics, antiperspirant

4-Viable Epidermis-Dermis
•anti-inflammatory, anaesthetics, antihistamine , antipruritic

5-Systemic treatment
•transdermal

77
Q

Transdermal drug delivery?

A

Delivering drugs across the stratum corneum and into the systemic circulation. Crossing epidermis, dermis till reaches vascular system in the dermis layer.

Greatest advance in transdermal drug delivery

Transdermal therapeutic system TTS:
designed to release drug at a rate below the maximal rate for controlled systemic therapy.

Advantages:
Avoids first-pass metabolism of drug liver
Consistent site of absorption ie no missing gut absorption window
Can give constant drug input rate
Can stop dosing by removing patch

Examples:
Transdermal scopolamine (hyoscine)-motion sickness

Transdermal nitroglycerin GTN-angina
Transdermal estradiol-HRT and menopause
Transdermal contraceptives-Ethinyl estradiol and noregestromin
Transdermal nicotine
Transdermal testosterone
Transdermal fentanyl

Drug penetration across the stratum corneum occurs via two routes intracellular route (between cells) or transcellular route (through the cells)

Transdermal drug delivery market is worth 2billion per year
In 2000 only eight drugs were in the market:
Scopolamine, nitroglycerin, clonidine, estradiol, nicotine, testosterone, fentanyl and notethisterone.

Why can’t all drugs be administered via the skin?
Complex process only few micrograms per hour can reach systemic circulation so drugs have to be potent and need to be in right formulation.

Maximal steady flux in the order of micro grams per hour.

Identifying candidate drugs for transdermal delivery?

Choice of drug candidate depends on:
Physicochemical nature if the drug
Potency of the drugs
Timescale of drug exposure
Site and condition of skin
Formulation
Alteration of skin barrier by formulation
Skin hydration

Potency of drug:

Low amounts of drugs crossing the skin means that most drugs delivered transdermally are potent I.e have ver low minimum effective concentration.

Transdermal drug delivery involves the administration of medications through the skin. Since the skin acts as a barrier, only a small amount of drug is able to cross into the bloodstream. Therefore, drugs delivered transdermally are often formulated to be potent, meaning they have a low minimum effective concentration. This ensures that even a small amount of the drug can produce the desired therapeutic effect.

78
Q

Factors affecting rate of transdermal drug transport?

A

•Time scale of drug exposure
Creams lotions ointments applied OD,BD,TDS
Patches applied OD or every 72hrs

•Site and condition of skin
SC thickness varies across body
Hirsute skin may be more permeable (especially to hydrophilic drugs that diffuse slowly through SC but faster through hair follicles)

•Skin hydration state
Hydrated skin is generally more permeable to drugs
Through to be due to looser packing of SC lipids. Less restrictive path to drug diffusion.

Open up the SC and can increase SC penetration 10-folds.

Formulations factors
Ointment, cream, lotion, gel
Aim is to maximise drug concentration gradient across SC
Use formulation techniques to achieve supersaturated concentrations

Alteration of skin barrier by formulation:
Can include penetration enhancers
Ointments are greasy and restrict loss from skin—> stratum corneum become more permeable

79
Q

Skin therapies in skin disorders

A

Many also used to treat other diseases and mechanisms of action are the same:

Antimicrobial agents: antibiotics, antifungals, antivirals for infections.
Glucocorticoids eg hydrocortisone
Antihistamines- puritis, eg eczema, insect stings eg crotamiton.
Drugs used to control hair growth-co-cyprindol (acne, hirsutism in women) finasteride (alopécica(, elfornithine (hirsutism), minoxidil (alopecia)

Retinoids-acne, eczema, psoriasis
Vitamin-D analogous psoriasis,dermatitis
Salicylic acid-keratolytic

Imiquimod-immune modifier for genital warts and basal cell cancer-possibly increases immune surveillance.
Biologicals anti-TNF treatments eg adalimumab and infliximab.

80
Q

Glucocorticoids

A

Target inflammation in the skin-psoriasis,eczema, pruritis

Classified as:
_Mild-hydrocortisone

_Moderate-alclomethasone dipropionate, clobetasone butyrate flusroxycortide, fluocortolone.

_Potent beclomethasone dipropionate, betamethasone esters.

_Very potent clobetasol propionate, diflucortolone valerate.

Choice depends on severity of disease and location (different skin thicknesses)
Used in combinations with antimicrobials in infection.

Mechanism of action
Inhibits release of inflammatory mediators, NF Kappa B, neutrophils activation and emigration, mast cell release, immune cell activation.

Side effects:
Short term, low potency generally safe
Prolonged usage can lead to:
Steroid rebound
Skin atrophy
Systemic effects
Spread of infection
Steroid rosacea in face
Stretch marks and superficial dilated blood vessels

81
Q

Retinoids Vit-A&D analogues

A

Disturbances in vitamin A metabolism disrupt skin
Retinoids acid has potent effects on skin homeostasis
Retinoid drugs include:
Tretinoin, isotretinoin, alitretinoin, tazarotene, adápalene.

Acne, eczema, psoriasis
Usually topical applications, oral in severe cases.

Mechanism of action:
Bind to RXR retinoid X or A receptor and RAR nuclear receptors in keratinocytes and sebaceous glands to decrease cell proliferation and sebum production.
Anti-inflammatory effects through pleiotropic actions on immune system

Side effects
Dry skin
Stinging
Burning sensation
Joint pains
Teratogenic

VitD analogues:

Mixture of related substances-calcitriol biologically active molecule

Act via VDR vitamin D receptors to modulate gene transcription in keratinocytes, fibroblasts, langerhans cells and sebaceous glands.

Anti-proliferative and pro-differentiative effects in keratinocytes.
Inhibit T cell production
Calcitriol, calcipotriol and tacalcitol are main analogues-psoriasis
Given topically
Side effects possible effects on bone and potential skin irritation.

82
Q

Eczema

A

Remove allergen/irritant if possible
Emollients-hydrate skin
Topical steroids
Topical calcineurin inhibitors- reduce inflammation through T-cell inhibiton
Phototherapy severe eczema
Oral corticosteroids severe eczema
Immunosuppressants chronic severe eczema
Antibiotics
Topical localised infection
Oral visibly infected skin

83
Q

Psoriasis

A

Emollients- hydrate skin
Vitamin D derivatives-maturation if epidermal cells
Topical steroids reduce epithelial turnover
Coal tar
Dithranol anti-proliferative
Keratolytics removes scale

Phototherapy moderate to sever psoriasis
Oral corticosteroids severe
Immunosuppressants methotrexate, Ciclosporin Severe
Accitretin if immunosuppressants ineffective
Anti-TNF antibodies last resort

84
Q

Eczema

A
85
Q

Atopic eczema management:

A

Topical corticosteroids adverse effects

Systemic side effects
More likely with potent corticosteroids
Long treatment duration > 2weeks
Large area

Localised side effects
Skin thinning
Within 1-3 weeks of starting a potent topical corticosteroids

Select lowest potency likely to work within 7-14days based upon:
Severity of inflammation
Response to previous treatment

Review in 7days
Stop or step up as necessary

•Mild eczema:
Manage trigger
Emollients
Mild topical steroids

•Moderate eczema
Manage trigger
Eminente
Moderate topical steroids
Topical calcineurin inhibitors
Bandages

•Severe eczema
Manage triggers
Emollients
Moderate topical steroid
Topical calcineurin inhibitors
Bandages
Phototherapy
Oral corticosteroids

86
Q

Topical calcineurin inhibitors

A

Tacrolimus
Pimecrolimus

Reduce inflammation through suppression of T-lymphocytes responses.

Suitable for use on face because they don’t cause skin atrophy like glucocorticoids but they cause local skin irritation redness.

Suitable for children aged over 2-years

87
Q

Bandaging

A

Occluding thr area
Prevent scratching
Keeps creams in contact with skin
Medicated or dry dressing
Over emollient of chronic lichenified eczema.

Over emollient and topical steroid for flare ups.
Maximum use of 7-14 days

88
Q

Phototherapy

A

Down regulation of inflammatory pathway

89
Q

Systemic agents

A

Corticosteroids e.g. Prednisolone:
Short term measure in severe or widespread eczemas
Gain control very rapidly
Not recommended for children

Immunosuppressants:
Ciclosporin-not recommended for children
Extremely effective in chronic severe eczema.

90
Q

Antibiotics

A

Antibiotics oral:

Treat visibly infected skin with oral antibiotics.

Flucloxacillin first line therapy
Erythromycin if penicillin allergic or resistant
Clarithromycin if erythromycin not tolerated

Treat with 1-2 week course

Staphylococci aureus 90% colonised
Swab from infected lesion if resistance suspected or not Staph.aureus infection.

Use topical antibiotics if localised small infection

Maximum of 2 weeks treatment
Advise general measures to prevent infection:
Not to leave tub open
Use clean spoons to remove cream
Reorder new pot of cream after an infection

91
Q

Antihistamine

A

Not for routine use only for pruritus most distressing feature
Trial with non sedating antihistamine
4weeks

Short term use of sedating antihistamine at night eg chlorphenamine, promethazine.

Promote sleep and reduce scratching
Topically cause sensitisation and have no place in management

92
Q

Psoriasis

A

Describe the incidence of psoriasis and its precipitating factors.

Explain the pathogenesis of psoriasis

List the clinical features and different types of psoriasis

Describe the rationale behind treatment of psoriasis

State the treatment used for the management of psoriasis.

93
Q

Chronic plaque psoriasis

A

Common type >80%

Plaques raised scaly sliver white flakes affects the elbows and knees

94
Q

Flexural inverse Psoriasis

A

Red glazed plaques confined to flexures
Groin, natal cleft, sun-mammary area

Usually no scale
Lesions are shiny and smooth
Skin very tender
Infection risk

95
Q

Guttate psorasis

A

Raindrop like
Common in children and young adults
Small circular plaques on trunk
2 weeks after streptococcal sore throat.

96
Q

Erthrodermic & pustular psoriasis

A

Most severe types:
Widespread intense inflammation of the skin

Maybe associated with malaise, pyrexia and circulatory disturbance

Can be life threatening:
Widespread skin shedding

97
Q

Management aims

A

•To hydrate the skin
Emollients

•To promote normal maturation of epidermal cells
Vitamin D derivatives

•To reduce epidermal cell turnover
Corticosteroids and cytotoxic agents

•To remove scale
Keratolytics

•To reduce inflammation and the immunological skin reaction
Immunosuppressants

98
Q

Treatment of psoriasis

A

•First line
Emollients
Vitamin D analogues
Topical corticosteroids
Dithranol
Coal Tar

•Second line
UVB and PUVA
Systemic non biological agents

•Third line
Systemic biological agents

99
Q

Emollients: creams, ointments

A

Smooth and smooth and hydrate
Apply regularly and liberally
Creams used as a soap substitute

Bath or shower emollients

Add to bath water
Apply to wet skin and rinse

100
Q

Vitamin D analogues

A

Inhibit T-cell activation
Antiproliferative effect & improved differentiation

Interfere with cytokine release

Anti-inflammatory

Calcipotriol (Dovonex) Tacalcitol (Curatoderm) Calcitriol (Silkis)

Cream and ointment apply OD or BD
Colourless, odourless and does not stain

Not for use on the face, flexures or genitals

101
Q

Topical corticosteroids

A

Moderate potency topical corticosteroids
Eg Clobetasone butyrate 0.05%
Stronger agents on palms and soles of feet

Reduce epidermal cell turnover
•Anti-inflammatory and antiproliferative

May lead to rebound exacerbation on discontinuation

Inappropriate for:
Widespread psoriasis
Long term use (max 8-weeks)

102
Q

Dithranol

A

Anti-proliferative effect on epidermal keratinocytes
Starts with low conc 0.05% increase gradually depending on tolerance max 3%

Proprietary preparations eg Dithrocream usually washed off after 50-60min (short contact)

Specialist intensive treatment overnight

Very irritant
Careful to avoid the normal skin
Difficult to use with many small lesionan

Stains skin, clothing and bath fittings

Unsuitable for face, flexures or acutely inflamed psoriasis.

Anti-proliferative effect inhibits thiamine thymidine from incorporating in the DNA and ATP supply to normal cells so it inhibits cell turnover.

103
Q

Coal Tar

A

Anti-inflammatory and keratolytic activity

Effective for inducing remission

Used for many years
Mostly used scalp psoriasis

Tar based shampoos available eg poly tar

Efficacy enhanced when used with UVB
Known carcinogen

104
Q

2nd line initiated by specialists

A

UVB and PUVA

Methotrexate and Ciclosporin
Acitretin

UVB
Slows cell proliferation
Light of wavelengths 290-320nm
Responsible for sunburn

Used alone or with emollients
Dose give 3X a week until clear
Usually for 4-6 weeks

PUVA
Psoralen UVA

Activated by UVA to interfere with DNA synthesis

Reduces epidermal cell turnover
Allows deeper penetration of UVA lightning

Eye protection
Dark goggles worn during and 8hours after treatment to prevent cataract

Skin cancers Ci if genetic risk of melanoma

105
Q

T-cell suppression

A

Systemic preparations
Methotrexate
Most effective treatment for psoriatic arthritis

1st line systemic agent
Antipoliferative ( antifoalte effect) and T cell suppressor

Ciclosporin
T-cell suppression

Renal function and blood pressure monitored
Avoid over exposure to the sun and should it receive concurrent UV therapy

106
Q

Acitretin

A

If methotrexate and Ciclosporin unsuccessfull
Oral vitamin D analogue

Buen to nuclear retinoid acid receptors

Involved in controlling development and maturation of cells

Induce keratinocytes differentiation and reduce epidermal hyperplasia

Teratogenic effects

Enhances the action of PUVA allowing a reduction in dose

107
Q

Systemic biological products

A

TNF antagonists

Reduce T cell mediated effects

Monoclonal antibodies
Adalimumab and infliximab

Fusion proteins
Etanercept

Most effective
60-80% having at least 75% improvement within 12 weeks

Long term side effects unknown
Infection
Increased malignant disease

Restricted use
Severe psoriasis only
Failed to respond to or can’t tolerate conventional systemic treatments

108
Q

Summary

A

Genetic pre-disposition
Cause and Pathophysiology unknown
Trigger factors exacerbate
Psychologicallly distressing condition
Treatment is symptomatic
Remove scale
Reduce over production of cells
Reduce inflammation
Improve maturation and hydrate